Affordable Access

Exploring changes in treatment effects across design stages in adaptive trials

John Wiley & Sons Ltd.
Publication Date
  • Rs Pharmacy And Materia Medica
  • Qa Mathematics
  • Design


The recently published committee for Medicinal Products for Human Use reflection paper on flexible designs highlights a controversial issue regarding the interpretation of adaptive trials. The guideline suggests that a test for heterogeneity should he preplanned and if treatment effect estimates differ significantly between design stages then data collected be ore and after the interim analysis might not be combined in a formal analysis. In this paper we investigate error rates for such a procedure ill the presence of calendar-time effects. Furthermore, we present all alternative testing strategy based oil change point methods. In a simulation study we demonstrate that our procedure performs well in comparison to that suggested by the guideline. Copyright (C) 2008 John Wiley & Sons, Ltd.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Multi-treatment optimal response-adaptive designs...

on Journal of the Korean Statisti... Jan 01, 2011

Adaptive designs for clinical trials assessing bio...

on British Journal of Cancer Apr 15, 2014

Compound adaptive GPU design for clinical trials

on Journal of Statistical Plannin... Jan 01, 2010
More articles like this..